EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BOTULINUM TOXIN FOR THE TREATMENT OF MICROSTOMIA IN SYSTEMIC SCLEROSIS: A LITERATURE REVIEW

Marta Dzhus, Oleksandra Rakashevych-Vodianytska

Anti-Aging Eastern Europe · 31.03.2026 · 5 (1) · 36-40

DOI: 10.56543/aaeeu.2026.5.1.04 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anti-Aging Eastern Europe, online erschienen am 31.03.2026. Verfasst von Marta Dzhus und 1 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic sclerosis (SSc) is a multisystem autoimmune disease characterized by brosis and vasculopathy, commonly leading to microstomia – an abnormally reduced oral aperture that impairs speech, nutrition, and quality of life. Conventional options for managing SSc-related microstomia – for example, stretching exercises, physiotherapy, and various surgical procedures – usually provide only partial or short lived improvement, and results vary widely between patients. Against this background, botulinum toxin (BoNT), a neuromuscular blocker already widely used in neurology and dermatology, has been suggested as an alternative approach to address perioral brosis and increase mouth opening in patients with SSc. This literature review summarizes the current evidence on the effectiveness and safety of BoNT injections for treating microstomia in SSc. We found only a few relevant clinical studies: one small prospective trial, one completed clinical trial (with results not yet available), a case series, and a single case report. These studies suggest that BoNT therapy can lead to short-term improvements in mouth opening and function, with few side effects. However, the data are limited by small sample sizes and a lack of controlled trials. BoNT looks promising as an additional treatment for SSc-related microstomia, but larger studies are needed to conrm its long-term benefts, best dosing, and safety.

Zitieren

APA

Dzhus, M., & Rakashevych-Vodianytska, O. (2026). BOTULINUM TOXIN FOR THE TREATMENT OF MICROSTOMIA IN SYSTEMIC SCLEROSIS: A LITERATURE REVIEW. Anti-Aging Eastern Europe, 5(1), 36-40. https://doi.org/10.56543/aaeeu.2026.5.1.04

Vancouver

Dzhus M, Rakashevych-Vodianytska O. BOTULINUM TOXIN FOR THE TREATMENT OF MICROSTOMIA IN SYSTEMIC SCLEROSIS: A LITERATURE REVIEW. Anti-Aging Eastern Europe. 2026;5(1):36-40. doi:10.56543/aaeeu.2026.5.1.04

BibTeX
@article{Dzhus2026,
  author = {Dzhus, Marta and Rakashevych-Vodianytska, Oleksandra},
  title = {BOTULINUM TOXIN FOR THE TREATMENT OF MICROSTOMIA IN SYSTEMIC SCLEROSIS: A LITERATURE REVIEW},
  journal = {Anti-Aging Eastern Europe},
  year = {2026},
  volume = {5},
  number = {1},
  pages = {36--40},
  doi = {10.56543/aaeeu.2026.5.1.04}
}
Kostenlos starten →